Peritoneal carcinomatosis after risk-reducing surgery in BRCA1/2 mutation carriers.

about

Peritoneal carcinomatosis after risk-reducing surgery in BRCA1/2 mutation carriers.

Item

http://www.wikidata.org/entity/Q47189965

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Peritoneal carcinomatosis after risk-reducing surgery in BRCA1/2 mutation carriers.

@en

Peritoneal carcinomatosis after risk-reducing surgery in BRCA1/2 mutation carriers.

@nl

type

Item

label

Peritoneal carcinomatosis after risk-reducing surgery in BRCA1/2 mutation carriers.

@en

Peritoneal carcinomatosis after risk-reducing surgery in BRCA1/2 mutation carriers.

@nl

prefLabel

Peritoneal carcinomatosis after risk-reducing surgery in BRCA1/2 mutation carriers.

@en

Peritoneal carcinomatosis after risk-reducing surgery in BRCA1/2 mutation carriers.

@nl

P1476

Peritoneal carcinomatosis after risk-reducing surgery in BRCA1/2 mutation carriers

@en

P2093

Joanne A de Hullu

http://www.w3.org/2001/XMLSchema#string

Jurgen M J Piek

http://www.w3.org/2001/XMLSchema#string

Leon F A G Massuger

http://www.w3.org/2001/XMLSchema#string

Marc van Beurden

http://www.w3.org/2001/XMLSchema#string

Marian J Mourits

http://www.w3.org/2001/XMLSchema#string

Mark H Greene

http://www.w3.org/2001/XMLSchema#string

Murray J Casey

http://www.w3.org/2001/XMLSchema#string

Timothy R Rebbeck

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis of BRCA1 and BRCA2 penetrance

Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers

Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.

Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.

The preclinical natural history of serous ovarian cancer: defining the target for early detection

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause.

Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.

P304

952-959

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.31211

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

Marline G Harmsen

Nicoline Hoogerbrugge

J Bulten

Brigitte F M Slangen

P577

2018-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29315498

http://www.w3.org/2001/XMLSchema#string